共 396 条
[1]
Mills MN(2020)Management of brain metastases in breast cancer: a review of current practices and emerging treatments Breast Cancer Res Treat 180 279-300
[2]
Figura NB(2006)Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer J Clin Oncol 24 5658-5663
[3]
Arrington JA(2009)Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases Eur J Cancer 45 2792-2798
[4]
Yu HM(2006)Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR Am J Surg Pathol 30 1097-1104
[5]
Etame AB(2015)Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study Neuro-Oncology 17 289-295
[6]
Vogelbaum MA(2013)Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study Lancet Oncol 14 64-71
[7]
Soliman H(2019)TBCRC 022: a phase II trial of Neratinib and Capecitabine for patients with human epidermal growth factor receptor 2-positive breast Cancer and brain metastases J Clin Oncol 37 1081-1089
[8]
Czerniecki BJ(2017)Adjuvant Capecitabine for breast Cancer after preoperative chemotherapy N Engl J Med 376 2147-2159
[9]
Forsyth PA(2011)Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. intergroup/RTOG 9704 phase III trial Ann Surg Oncol 18 1319-1326
[10]
Han HS(2013)RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal Int J Radiat Oncol Biol Phys 86 27-33